InFlectis BioScience Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • (In Progress)
  • Investors
  • 6

InFlectis BioScience General Information

Description

Developer of small molecule drugs intended to improve cellular defense system. The company's small molecule drugs identify preclinical-stage development products that modulate key proteins involved in misfolded protein disorders areas through early proof-of-concept, enabling clients to maximize the commercial value of each of its products, improve patient care and generate significant financial returns to its shareholders.

Contact Information

Website
www.inflectisbioscience.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 21 rue La Noue Bras de Fer
  • 44200 Nantes
  • France
+33 02 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InFlectis BioScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 04-Jan-2021 00.000 In Progress Clinical Trials - Phase 2
3. Early Stage VC (Series A) 27-May-2016 00.00 00.000 Completed Generating Revenue
2. Seed Round 13-Jan-2015 $2.11M $2.11M Completed Generating Revenue
1. Grant 01-Jan-2014 $411K Completed Generating Revenue
To view InFlectis BioScience’s complete valuation and funding history, request access »

InFlectis BioScience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small molecule drugs intended to improve cellular defense system. The company's small molecule drugs identi
Drug Discovery
Nantes, France
10 As of 2020
00.000
0000000000 0 00.000

00000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
0000000000000
San Francisco, CA
00 As of 0000
000.00
000000000 - 000.00

0000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
0000 000000000
Lyon, France
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InFlectis BioScience Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BlueLight Therapeutics Venture Capital-Backed San Francisco, CA 00 000.00 000000000 - 000.00
0000000 000000 Formerly VC-backed Lyon, France 000 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed New Haven, CT 00 0000 00000000000 0000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 37 competitors. Get the full list »

InFlectis BioScience Executive Team (4)

Name Title Board Seat Contact Info
Philippe Guedat Ph.D Co-Founder, Chief Executive Officer, Chairman, Managing Director & President
Philippe Jaffré Chief Financial Officer
Pierre Miniou Ph.D Co-Founder, Chief Operating Officer, Chief Business Officer & Board Member
Anne Visbecq MD Chief Medical Officer
To view InFlectis BioScience’s complete executive team members history, request access »

InFlectis BioScience Board Members (6)

Name Representing Role Since
Emilie Lidome Self Board Member 000 0000
Jérôme Guéret GO Capital (France) Board Member 000 0000
Philippe Guedat Ph.D InFlectis BioScience Co-Founder, Chief Executive Officer, Chairman, Managing Director & President 000 0000
Pierre Miniou Ph.D InFlectis BioScience Co-Founder, Chief Operating Officer, Chief Business Officer & Board Member 000 0000
Taro Inaba Remiges Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

InFlectis BioScience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InFlectis BioScience Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Remiges Ventures Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
Participations Besançon Family Office Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial